Akero’s Fatty Liver Disease Drug Lessens Scarring in Mid-stage Trial
(Reuters) -Akero Therapeutics' experimental drug for a type of fatty liver disease significantly reduced scarring after nearly two years in ...
Read moreDetails(Reuters) -Akero Therapeutics' experimental drug for a type of fatty liver disease significantly reduced scarring after nearly two years in ...
Read moreDetails© 2023 earth-news.info
© 2023 earth-news.info